Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionMAb against proprotein convertase subtilisin/kexin type 9 (PCSK9)
Molecular Target Proprotein convertase subtilisin/kexin type 9 (PCSK9)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationHypercholesterolemia
Indication DetailsTreat hypercholesterolemia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today